YU78703A - Derivati merkaptoacetilamida, postupak za njihovo pripremanje i njihova upotreba - Google Patents
Derivati merkaptoacetilamida, postupak za njihovo pripremanje i njihova upotrebaInfo
- Publication number
- YU78703A YU78703A YU78703A YUP78703A YU78703A YU 78703 A YU78703 A YU 78703A YU 78703 A YU78703 A YU 78703A YU P78703 A YUP78703 A YU P78703A YU 78703 A YU78703 A YU 78703A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- compounds
- preparation
- disclosed
- mercaptoacetylamide derivatives
- mercaptoacetylamide
- Prior art date
Links
- GYXHHICIFZSKKZ-UHFFFAOYSA-N 2-sulfanylacetamide Chemical class NC(=O)CS GYXHHICIFZSKKZ-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 102000003729 Neprilysin Human genes 0.000 abstract 1
- 108090000028 Neprilysin Proteins 0.000 abstract 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 abstract 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Ovaj pronalazak otkriva i daje u patentnim zahtevima seriju derivata merkaptoacetilamida formule (I).. Ovde su takodje otkrivene i date u patentnim zahtevima farmaceutske kompozicije koje obuhvataju ova jedinjenja i postupci za pripremanje pomenutih jedinjenja. Upotreba pomenutih jedinjenja za inhibiciiju enzima koji konvertuje angiotenzin i neutralnih endopeptidaza i za lečenje hipertenzije ikongestivnog poremećaja srca su takodje ovde otkriveni i dati u patentnim zahtevima.[This invention discloses and claims a series of mercaptoacetylamide derivatives of formula (I). Also disclosed and claimed are pharmaceutical compositions incorporating these compounds and processes for preparing said compounds. The use of said compounds for inhibition of the enzymes angiotensin converting enzyme and neutral endopeptidase, and for the treatment of hypertension and congestive heart failure are also disclosed and claimed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28330501P | 2001-04-12 | 2001-04-12 | |
GBGB0119305.1A GB0119305D0 (en) | 2001-04-12 | 2001-08-08 | Mercaptoacetylamide derivatives,a process for their preparation and their use |
Publications (2)
Publication Number | Publication Date |
---|---|
YU78703A true YU78703A (sh) | 2006-05-25 |
RS50919B RS50919B (sr) | 2010-08-31 |
Family
ID=23085405
Country Status (17)
Country | Link |
---|---|
US (1) | US6602866B2 (sh) |
KR (1) | KR100910929B1 (sh) |
AR (1) | AR034307A1 (sh) |
CR (1) | CR7074A (sh) |
DK (1) | DK1381605T3 (sh) |
EC (1) | ECSP034782A (sh) |
GB (1) | GB0119305D0 (sh) |
GT (1) | GT200200069A (sh) |
IL (1) | IL158289A (sh) |
MY (1) | MY128226A (sh) |
PE (1) | PE20021079A1 (sh) |
RS (1) | RS50919B (sh) |
TN (1) | TNSN03083A1 (sh) |
TW (1) | TWI319764B (sh) |
UA (1) | UA75647C2 (sh) |
UY (1) | UY27255A1 (sh) |
ZA (1) | ZA200307096B (sh) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003244467A1 (en) * | 2002-02-04 | 2003-09-02 | Kaneka Corporation | Process for production of optically active 2-halogeno- carboxylic acids |
TW200838501A (en) * | 2007-02-02 | 2008-10-01 | Theravance Inc | Dual-acting antihypertensive agents |
TWI448284B (zh) | 2007-04-24 | 2014-08-11 | Theravance Inc | 雙效抗高血壓劑 |
TWI406850B (zh) * | 2007-06-05 | 2013-09-01 | Theravance Inc | 雙效苯并咪唑抗高血壓劑 |
US7834041B2 (en) | 2007-09-07 | 2010-11-16 | Theravance, Inc. | Dual-acting antihypertensive agents |
AU2008350907A1 (en) | 2007-12-11 | 2009-08-27 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
WO2009076288A1 (en) | 2007-12-11 | 2009-06-18 | Theravance, Inc. | Dual-acting benzoimidazole derivative and their use as antihypertensive agents |
EP2297113A1 (en) | 2008-04-29 | 2011-03-23 | Theravance, Inc. | Dual-acting antihypertensive agents |
WO2010011821A2 (en) | 2008-07-24 | 2010-01-28 | Theravance, Inc. | Dual-acting antihypertensive agents |
JP5833000B2 (ja) | 2009-07-07 | 2015-12-16 | セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー | 二重に作用するピラゾール抗高血圧症薬 |
EP2456762B1 (en) | 2009-07-22 | 2013-10-16 | Theravance, Inc. | Dual-acting oxazole antihypertensive agents |
WO2011090929A1 (en) | 2010-01-19 | 2011-07-28 | Theravance, Inc. | Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents |
KR101892500B1 (ko) | 2010-12-15 | 2018-08-28 | 세라밴스 바이오파마 알앤디 아이피, 엘엘씨 | 네프릴리신 억제제 |
WO2012082857A1 (en) | 2010-12-15 | 2012-06-21 | Theravance, Inc. | Neprilysin inhibitors |
WO2012154249A1 (en) | 2011-02-17 | 2012-11-15 | Theravance, Inc. | Substituted aminobutyric derivatives as neprilysin inhibitors |
MY163394A (en) | 2011-02-17 | 2017-09-15 | Theravance Biopharma R&D Ip Llc | Substituted aminobutyric derivates as neprilysin inhibitors |
CA2835281A1 (en) | 2011-05-31 | 2012-12-06 | Theravance, Inc. | Neprilysin inhibitors |
CN103582630B (zh) | 2011-05-31 | 2016-08-17 | 施万生物制药研发Ip有限责任公司 | 脑啡肽酶抑制剂 |
JP5959074B2 (ja) | 2011-05-31 | 2016-08-02 | セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー | ネプリライシン阻害剤 |
TWI560172B (en) | 2011-11-02 | 2016-12-01 | Theravance Biopharma R&D Ip Llc | Neprilysin inhibitors |
ES2609810T3 (es) | 2012-05-31 | 2017-04-24 | Theravance Biopharma R&D Ip, Llc | Inhibidores de neprilisina donadores de óxido nítrico |
WO2013184934A1 (en) | 2012-06-08 | 2013-12-12 | Theravance, Inc. | Neprilysin inhibitors |
ES2710932T3 (es) | 2012-06-08 | 2019-04-29 | Theravance Biopharma R&D Ip Llc | Inhibidores de neprilisina |
PT2882716T (pt) | 2012-08-08 | 2017-03-13 | Theravance Biopharma R&D Ip Llc | Inibidores da neprilisina |
CA2902456A1 (en) | 2013-03-05 | 2014-09-12 | Theravance Biopharma R&D Ip, Llc | Neprilysin inhibitors |
CA2934936A1 (en) | 2014-01-30 | 2015-08-06 | Theravance Biopharma R&D Ip, Llc | Neprilysin inhibitors |
JP2017504625A (ja) | 2014-01-30 | 2017-02-09 | セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー | ネプリライシン阻害剤としての5−ビフェニル−4−ヘテロアリールカルボニルアミノ−ペンタン酸誘導体 |
ES2923002T3 (es) | 2015-02-11 | 2022-09-22 | Theravance Biopharma R&D Ip Llc | Acido (2S,4R)-5-(5'-cloro-2'-fluorobifenil-4-il)-4-(etoxioxailamino)-2-hidroximetil-2-metilpentanoico como inhibidor de la neprilisina |
SI3259255T1 (sl) | 2015-02-19 | 2021-04-30 | Theravance Biopharma R&D Ip, Llc | (2R,4R)-5-(5'-kloro-2'-fluorobifenil-4-IL)-2-hidroksi-4-((5-metiloksa- zol-2-karbonil)amino)pentanojska kislina |
US10100021B2 (en) | 2016-03-08 | 2018-10-16 | Theravance Biopharma R&D Ip, Llc | Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3334095A (en) | 1965-02-16 | 1967-08-01 | Sandoz Ag | Novel pyrrolo-oxazines and pyrrolo-oxazoles |
US3334091A (en) | 1965-03-25 | 1967-08-01 | Sandoz Ag | Sedatives |
GB1525845A (en) | 1976-07-30 | 1978-09-20 | Ucb Sa | 1,2,4,5-tetrahydro-3h-2-benzazepin-3-ones |
IE50839B1 (en) | 1980-02-26 | 1986-07-23 | Wyeth John & Brother Ltd | Novel processes for preparing proline derivatives and analogous compounds |
EP0042100A1 (de) | 1980-06-13 | 1981-12-23 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Pyrazolopyridazin-Derivate, Zwischenprodukte und Verfahren zu deren Herstellung, sowie diese enthaltende Arzneimittel |
US4320057A (en) | 1980-06-23 | 1982-03-16 | American Home Products Corporation | Aryl--pyrrolo--thiazepin--diones and aryl--piperidino--thiazepin--diones |
US4415496A (en) | 1981-03-23 | 1983-11-15 | Merck & Co., Inc. | Bicyclic lactams |
GB2128984B (en) | 1982-05-12 | 1985-05-22 | Hoffmann La Roche | Diaza-bicyclic compounds |
ZA833214B (en) | 1982-05-12 | 1983-12-28 | Hoffmann La Roche | Bicyclic compounds |
US4552889A (en) | 1983-06-09 | 1985-11-12 | Eli Lilly And Company | 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension |
US4692438A (en) | 1984-08-24 | 1987-09-08 | Hoffmann-La Roche Inc. | Pyridazo-diazepines, diazocines, and -triazepines having anti-hypertensive activity |
US4584294A (en) | 1984-11-07 | 1986-04-22 | Merck & Co., Inc. | Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents |
CA1274832A (en) | 1985-04-30 | 1990-10-02 | Richard Elmer Holmes | 7-substituted bicyclic pyrazolidinones |
ZA874106B (en) | 1986-06-13 | 1987-12-08 | Merrell Dow Pharmaceuticals Inc. | Novel antihypertensive agent |
US4973585A (en) | 1986-06-13 | 1990-11-27 | Merrell Dow Pharmaceuticals | Tricyclic lactams active as antihypertensive agents |
ZA874107B (sh) | 1986-06-13 | 1987-12-09 | ||
GB8629875D0 (en) | 1986-12-15 | 1987-01-28 | Hoffmann La Roche | Pyridazodiazepine derivatives |
US4824832A (en) | 1987-12-30 | 1989-04-25 | Merrell Dow Pharmaceuticals Inc. | Sulfhydryl containing tricyclic lactams and their pharmacological methods of use |
GB8926512D0 (en) | 1989-11-23 | 1990-01-10 | Pfizer Ltd | Therapeutic agents |
US5407960A (en) | 1989-12-22 | 1995-04-18 | Schering Corporation | Mercaptocycloacyl aminoacid endopeptidase inhibitors |
CA2053340C (en) | 1990-10-18 | 2002-04-02 | Timothy P. Burkholder | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
US5491143A (en) | 1990-10-18 | 1996-02-13 | Merrell Dow Pharmaceuticals Inc. | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE |
US5430145A (en) * | 1990-10-18 | 1995-07-04 | Merrell Dow Pharmaceuticals Inc. | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
NZ241023A (en) | 1990-12-21 | 1994-10-26 | Merrell Dow Pharma | Condensed benzazepine derivatives and pharmaceutical compositions |
US5208230A (en) | 1990-12-21 | 1993-05-04 | Merrell Dow Pharmaceuticals | Amino and nitro containing tricyclic compounds useful as inhibitors of ACE |
FR2679564A1 (fr) | 1991-07-23 | 1993-01-29 | Inst Nat Sante Rech Med | Nouveaux acylmercaptoalcanoldipeptides, leur preparation et les compositions qui les contiennent. |
AU2650692A (en) | 1991-09-16 | 1993-04-27 | Schering Corporation | Pharmaceutical compositions comprising natriuretic peptides or neutral endopeptidase inhibitors for treating or preventing myointimal proliferation |
ES2106112T3 (es) | 1991-09-27 | 1997-11-01 | Merrell Pharma Inc | Derivados de indano-2-mercaptoacetilamida con una actividad inhibidora de encefalinasa y de ace. |
AU657793B2 (en) | 1991-09-27 | 1995-03-23 | Merrell Pharmaceuticals Inc. | Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE |
DE69317764T2 (de) | 1992-02-14 | 1998-07-30 | Merrell Pharma Inc | Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung |
DE69325904T2 (de) | 1992-05-15 | 1999-12-09 | Merrell Pharma Inc | MERCAPTOACETYLAMIDE VON PYRIDAZO[1,2-a][1,2]-DIAZEPIN -DERIVATEN ALS EUKEPHALINASE UND ACE-INHIBITOREN |
RU2124503C1 (ru) | 1992-05-18 | 1999-01-10 | И.Р.Сквибб энд Санз, Инк. | Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция |
US5238932A (en) | 1992-05-20 | 1993-08-24 | Merrell Dow Pharmaceuticals Inc. | Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
CA2140553A1 (en) * | 1993-06-11 | 1994-12-22 | Hitoshi Oinuma | Amino acid derivative |
US5525723A (en) | 1993-11-18 | 1996-06-11 | Bristol-Myers Squibb Co. | Compounds containing a fused multiple ring lactam |
WO1995021839A1 (en) * | 1994-02-14 | 1995-08-17 | Merrell Pharmaceuticals Inc. | Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
ATE246927T1 (de) * | 1994-03-24 | 2003-08-15 | Merrell Pharma Inc | Cholesterin senkende mercaptoacetylamiddisulfidderivate |
-
2001
- 2001-08-08 GB GBGB0119305.1A patent/GB0119305D0/en not_active Ceased
-
2002
- 2002-03-04 UA UA20031110184A patent/UA75647C2/uk unknown
- 2002-04-03 RS YUP-787/03A patent/RS50919B/sr unknown
- 2002-04-03 DK DK02732549T patent/DK1381605T3/da active
- 2002-04-03 KR KR1020037013181A patent/KR100910929B1/ko not_active IP Right Cessation
- 2002-04-08 US US10/118,179 patent/US6602866B2/en not_active Expired - Lifetime
- 2002-04-10 TW TW091107133A patent/TWI319764B/zh not_active IP Right Cessation
- 2002-04-10 GT GT200200069A patent/GT200200069A/es unknown
- 2002-04-10 AR ARP020101321A patent/AR034307A1/es active IP Right Grant
- 2002-04-10 UY UY27255A patent/UY27255A1/es not_active Application Discontinuation
- 2002-04-10 PE PE2002000294A patent/PE20021079A1/es not_active Application Discontinuation
- 2002-04-10 MY MYPI20021326A patent/MY128226A/en unknown
-
2003
- 2003-07-08 TN TNPCT/EP2002/003668A patent/TNSN03083A1/en unknown
- 2003-09-11 ZA ZA200307096A patent/ZA200307096B/en unknown
- 2003-09-12 CR CR7074A patent/CR7074A/es not_active Application Discontinuation
- 2003-09-26 EC EC2003004782A patent/ECSP034782A/es unknown
- 2003-10-07 IL IL158289A patent/IL158289A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20020193589A1 (en) | 2002-12-19 |
GB0119305D0 (en) | 2001-10-03 |
MY128226A (en) | 2007-01-31 |
PE20021079A1 (es) | 2003-02-19 |
UA75647C2 (en) | 2006-05-15 |
IL158289A (en) | 2010-11-30 |
CR7074A (es) | 2007-12-04 |
ZA200307096B (en) | 2004-09-06 |
KR20040008153A (ko) | 2004-01-28 |
ECSP034782A (es) | 2003-12-01 |
KR100910929B1 (ko) | 2009-08-06 |
DK1381605T3 (da) | 2005-05-09 |
US6602866B2 (en) | 2003-08-05 |
AR034307A1 (es) | 2004-02-18 |
GT200200069A (es) | 2002-12-17 |
TWI319764B (en) | 2010-01-21 |
TNSN03083A1 (en) | 2005-12-23 |
RS50919B (sr) | 2010-08-31 |
UY27255A1 (es) | 2002-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN03083A1 (en) | Mercaptoacetylamide derivatives, a process for their preparation and their use | |
WO2004011453A3 (en) | Method for preparing 3-halo-4,5-dihydro-1h-pyrazoles | |
NO20006645L (no) | Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme | |
WO2003082857A3 (en) | Lansoprazole polymorphs and processes for preparation thereof | |
NO20060417L (no) | Fremgangsmate til fremstilling av 1-okten fra krakk-C4 | |
WO2002065834A3 (en) | Novel formulations of carvedilol | |
PL371127A1 (en) | 6-aminomorphinane derivatives, method for the production and use thereof | |
AP1766A (en) | Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation. | |
WO2002010152A3 (de) | Neue indolderivate und deren verwendung als arzneimittel | |
SG165159A1 (en) | Process for preparing 6-alkylidene penem derivatives | |
WO2005051401A3 (en) | Prevention and treatment of hypertensive heart diseases by the selective estrogens 8beta-vinyl-estra-1,3,5(10)-trien-3,17beta-diol and 17beta-fluor-9alpha-vinyl-estra-1,3,5(10)-trien-3,16alpha-diol | |
IL158289A0 (en) | Mercaptoacetylamide derivatives, a process for their preparation and their use | |
WO2003080631A3 (en) | Plasma carboxypeptidase b inhibitors | |
WO2003035651A3 (fr) | Derives de l'artemisinine, et leurs utilisations dans le traitement du paludisme | |
PT1651596E (pt) | Novos derivados de 4,4?-ditiobis-(3-aminobutano-1-sulfonatos) e composições que os contêm | |
WO2003028645A3 (en) | Novel compositions of carvedilol | |
WO2002085877A3 (en) | Processes and intermediates for preparing benzyl substituted epoxides | |
AU2002326391A1 (en) | Carvedilol polymorph | |
MXPA05003881A (es) | Preparacion de compuestos triazospiro. | |
MXPA04001852A (es) | Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad. | |
MXPA04002879A (es) | Procedimiento para preparar derivados de heterocicloalquilsulfonilpirazol. | |
MXPA04001846A (es) | Indan-1-onas c2-substituidas y sus derivados, metodos para su produccion y su uso como medicamentos. | |
MXPA04001851A (es) | Inda-1-onas c2-disustituidas y sus derivados, metodo para su produccion y su uso como medicamentos. | |
AU2001244537A1 (en) | Use of natural compounds having antiangiogenic activity | |
WO2003092626A3 (en) | Carvedilol pharmasolve solvate |